By using a multiscale modelling approach, the biochemical reactions of fibrinolysis are integrated with macroscale blood flow and drug transport in a 3D patient-specific model to assess the effects of different tPA doses on the outcome of thrombolytic therapy for AIS and the risk of ICH. Here, PLAT is linked to androgen insensitivity syndrome.